Home
Scholarly Works
In ACS with planned invasive evaluation, prasugrel...
Journal article

In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.

Authors

Raco DL

Journal

Annals of Internal Medicine, Vol. 172, No. 2,

Publisher

American College of Physicians

Publication Date

January 21, 2020

DOI

10.7326/acpj202001210-005

ISSN

1056-8751

Contact the Experts team